Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 8,000 shares at $10.15 ($81K) on 2022-02-01, disclosed to the SEC on 2022-02-03.
Open-market sale of $81k YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |